DUBLIN/CA/USA, OBERKOCHEN/Germany | 15. July 2019 | Corporate News
The internationally leading optics and optoelectronics technology enterprise ZEISS completed the “steel topping out” phase of its new high tech site in the San Francisco Bay Area.
The new site in Dublin is an integral part of ZEISS’ global investment strategy and is one element in a string of international projects aimed at expanding, modernizing and realigning sites that ZEISS has been implementing in locations such as Germany, Europe and Asia since 2011.
“Our investments are focused on leveraging the existing potential in our growth markets,” explains Dr. Christian Mueller, Member of the Executive Board and CFO of the ZEISS Group. “As a global technology leader, we need an even stronger presence and better networking at the innovation hotspots.”
The new center will encompass 208,650 square feet with three floors. It is scheduled for completion in the fourth quarter of 2020 and will bring together multiple ZEISS segments under one roof to create a place for up to 700 workspaces.
Dublin will serve as the US headquarters for ZEISS Medical Technology, with ZEISS Industrial Quality & Research and ZEISS Semiconductor Manufacturing Technology also being located there. The facility will feature customer experience centers for Medical Technology and Microscopy, along with digital training rooms for employees and customers to thrive and to bring customers the best solutions to meet their needs.
To continue fostering the entrepreneurial spirit of innovation that is at ZEISS’ core, the Dublin high tech site is devoted to developing innovations that shape our world now and in the future in the San Francisco Bay Area, a vibrant center of technology.
It is located on 13.5 acres, near the I-580 and I-680 interchange and within walking distance of two BART stations with access to San Francisco and Oakland. The facility will be built according to sustainable principles.
ZEISS North America has facilities in both the US and Canada with offices located on the West Coast, East Coast and in the Central geographies employing over 3,200 people.
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling more than 5.8 billion euros in its four segments Industrial Quality & Research, Medical Technology, Consumer Markets and Semiconductor Manufacturing Technology (status: 30 September 2018).
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future far beyond the optics and optoelectronics industries. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership.
With approximately 30,000 employees, ZEISS is active globally in almost 50 countries with around 60 of its own sales and service companies, more than 30 production sites and around 25 development sites. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.
Further information at www.zeiss.com